IP Library Granted Patent US 10,662,136
Granted Patent B2
US 10,662,136 · App. 15/975,630 · Granted May 26, 2020

Process of separating components of a fermentation broth

Inventors: Warren Clark (Yale, OK); Michael Japs (San Diego, CA); Mark J. Burk (San Diego, CA)
Assignee: Genomatica, Inc.
C07C29/76C12P7/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,662,136
App. No.
15/975,630
Granted
May 26, 2020
Kind
B2
Abstract

A process of isolating 1,4-butanediol (1,4-BDO) from a fermentation broth includes separating a liquid fraction enriched in 1,4-BDO from a solid fraction comprising cells, removing water from said liquid fraction, removing salts from said liquid fraction, and purifying 1,4-BDO. A process for producing 1,4-BDO includes culturing a 1,4-BDO-producing microorganism in a fermentor for a sufficient period of time to produce 1,4-BDO. The 1,4-BDO-producing microorganism includes a microorganism having a 1,4-BDO pathway having one or more exogenous genes encoding a 1,4-BDO pathway enzyme and/or one or more gene disruptions. The process for producing 1,4-BDO further includes isolating 1,4-BDO.

Claims (18)

1. A process of isolating 1,4-butanediol (1,4-BDO) from a fermentation broth, the process consisting of:

separating a liquid fraction enriched in 1,4-BDO from a solid fraction of the fermentation broth comprising cells in a separation step consisting of filtration, wherein the filtration consists of ultrafiltration, and wherein the fermentation broth comprises 1,4-BDO at a concentration of about 5%-15% by weight of 1,4-BDO;

removing salts from the liquid fraction, wherein removing the salts comprises nanofiltration followed by ion exchange;

removing water from said liquid fraction, and

purifying 1,4-BDO from the liquid fraction by distillation after removing salts and water; to produce a 1,4-BDO product at least 98% pure.

2. The process of claim 1 , wherein ultrafiltration comprises filtering through a membrane having a pore size from about 0.005 to about 0.1 microns.

3. The process of claim 1 , wherein removing water is accomplished by evaporation with an evaporator system comprising one or more effects.

4. The process of claim 3 , wherein said evaporator system comprises a double- or triple-effect evaporator.

5. The process of claim 3 , wherein said evaporator system further comprises a thermal recompressor.

6. The process of claim 3 , wherein said evaporator system further comprises a mechanical recompressor.

7. The process of claim 3 , wherein said evaporator system comprises an evaporator selected from the group consisting of a falling film evaporator, a short path falling film evaporator, a forced circulation evaporator, a plate evaporator, a circulation evaporator, a fluidized bed evaporator, a rising film evaporator, a counterflow-trickle evaporator, a stirrer evaporator, and a spiral tube evaporator.

8. The process of claim 3 , wherein said evaporator system comprises a vacuum.

9. The process of claim 1 , wherein substantially all of the salts are removed prior to removal of water.

10. The process of claim 1 , wherein nanofiltration comprises filtering through a membrane having a pore size range from about 0.0005 to about 0.005 microns.

11. The process of claim 1 , wherein substantially all of the salts are removed after removal of water.

12. The process of claim 1 , wherein the salts are partially removed, followed by removal of substantially all of the water, and then remaining salts are removed.

13. The process of claim 1 , wherein removing salts further comprises crystallizing salts.

14. The process of claim 1 , wherein removing salts further comprises precipitating salts by water removal.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →